News
Axon, Q2
StockStory.org on MSN5h
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q2 Sales Beat Estimates But Stock Drops 13.5%Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported in Q2 CY2025, with sales up 12.1% year on year to $2.96 billion ...
Global live streaming viewership grew 5% year-over-year to 9.1 billion hours watched during 2025 Q2, reflecting the highest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results